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Purpose: This study aimed to examine the psychometric properties and performance of a 
Chinese version of the Female Sexual Function Index (FSFI) among a sample of Chinese 
women with cervical cancer. 
 
Methods: A cross-sectional survey design was used. The respondents included 215 women 
with cervical cancer in an oncology hospital in China. A translated Chinese version of the 
FSFI was used to investigate their sexual functioning. Psychometric testing included internal 
consistency reliability (Cronbach’s alpha coefficient and item-total correlations), test-retest 
reliability, construct validity (principal component analysis via oblique rotation and 
confirmatory factor analysis), and variability (floor and ceiling effects). 
 
Results: The mean score of the total scale was 20.65±4.77. The Cronbach values were 0.94 
for the total scale, 0.72-0.90 for the domains. Test-retest correlation coefficients over 2-4 
weeks were 0.84 (p < 0.05) for the total scale, 0.68-0.83 for the subscales. Item-total 
correlation coefficients ranged between 0.47 and 0.83 (p < 0.05). A five-factor model was 
identified via principal component analysis and established by confirmatory factor analysis, 
including desire/arousal, lubrication, orgasm, satisfaction, and pain. There was no evidence of 
floor or ceiling effects. 
 
Conclusions: With good psychometric properties similar to its original English version, this 
Chinese version of the FSFI is demonstrated to be a reliable and valid instrument that can be 
used to assess sexual functioning of women with cervical cancer in China. Future research is 
still needed to confirm its psychometric properties and performance among a large sample.  
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INTRODUCTION 
Cervical cancer is seen as the second most common cancer affecting women worldwide, 
with an estimation of 530 000 new cases and more than 270 000 deaths annually due to this 
disease (WHO, 2013). Of these deaths, 85% occur in low and middle income countries, 
where the disease is the second largest cancer killer of women (WHO, 2013; Cervical 
Cancer-Free Coalition, 2014). In China, cervical cancer is the most common type of cancer 
affecting females with an estimated 33 914 deaths each year; the second highest number of 
women dying annually from the disease globally (Chen et al., 2013; Cervical Cancer-Free 
Coalition, 2014). 
The current treatment for cervical cancer includes surgery, radiotherapy and 
chemotherapy, depending on how far the cancer has spread (NHS, 2014). These treatments 
often cause significant physiological and anatomical changes and complications such as 
shortened vagina, vaginal dryness and dyspareunia, and consequently have an adverse effect 
on a women’s quality of life and her ability to engage in sexual intercourse (Wilmoth and 
Spinelli, 2000; Reis et al., 2010). Findings of empirical research have shown that women with 
cervical cancer often report less sexual interest, a decrease in sexual activity, dyspareunia, 
lack of lubrication, and low sexual satisfaction (Bergmark et al., 2002; Donovan et al., 2007; 
Jeffery et al., 2009; Levin et al., 2010; Lammerink et al., 2012). 
Female sexual dysfunction (FSD) is regarded as a group of disorders with physiological 
and psychological changes that have an adverse impact on a woman’s quality of life and 
interpersonal relationships (American Psychiatric Association & American Psychiatric 
Association, 2000). FSD is often defined as persistent or recurrent disorders of desire/libido, 
arousal, pain/discomfort, and inhibited orgasm associated with sexual intercourse (American 
Psychiatric Association & American Psychiatric Association, 2000; Rosen et al., 2000). 
Based on the framework of the International Classification of Diseases-10 and DSM-IV: 
Diagnosis and Statistical Manual of Mental Disorders of the American Psychiatric 
Association, an international consensus conference panel have expanded the existing 
classifications of FSD to include psychogenic and organic causes of desire (hypoactive sexual 
desire disorder and sexual aversion disorder), arousal, orgasmic, and pain disorders 
(dyspareunia, vaginismus and other sexual pain disorders) (Basson et al., 2001). 
Despite the high prevalence of sexual dysfunction among cervical cancer patients, it was 
not until the last decade that some psychometrically sound measures written in English were 
developed to assess FSD. Of these, the Female Sexual Function Index (FSFI) is widely used 
in research (Rosen, 2002; DeRogatis, 2008) and has been translated into many different 
languages (Berne et al., 2004; Rellini et al., 2005; Pechorro et al., 2012; Wylomanski et al., 
2014). The FSFI was originally developed in the USA to assess six domains of FSD, 
including desire, arousal, lubrication, orgasm, satisfaction, and pain. The scale has also been 
validated in female survivors of various cancers in the USA and Australia, with good 
psychometric properties reported (Baser et al., 2012; Bartula and Sherman, 2015). However, 
there is no reliable evidence that the FSFI is a valid scale to assess sexual functioning of 
women with cervical cancer in China.  
In China, little attention has been paid to FSD mainly because of the Chinese traditional 
ideology in relation to sex and sexual behaviour. Following a detailed literature search, only 
one validated questionnaire was found in the Chinese language (Sexual Quality of Life 
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Questionnaire for Women) to assess female sexual functioning (Hu and Hu, 2008). The 
questionnaire consists of 32 items arranged in six subscales, including satisfaction，
communication，anxiety，sexual response，attitude, and self-image. However, the scale, 
validated with healthy women, assesses only some common domains of sexual dysfunction, 
limiting its use in cervical cancer patients. 
 
AIMS 
This study aimed to examine the psychometric properties and performance of a 





A cross-sectional survey design was used.  
 
Sample  
The study was conducted with a convenience sample of cervical cancer patients in an 
oncology hospital in Hunan province, China. Participants were approached by nurses who 
were not part of, but trained by, the research team. Eligible criteria for participation included: 
women who were aged 18 years or over, were married or cohabitating, had surgery for 
cervical cancer at least three months before data collection, were either outpatients attending 
consultation at a gynaecology department or inpatients receiving radiotherapy and/or 
chemotherapy, and were native Chinese language speakers. 
 
Data collection 
The data were collected between June and December 2013. A study information 
package was distributed to 289 patients, containing an information sheet, a consent form, and 
questionnaires. The questionnaires were administered twice 2-4 weeks apart and were 
self-completed by patients. In total, 284 patients completed both assessments and returned 
their questionnaires. Of these, 69 respondents had no sexual intercourse in the preceding 
month, and so their responses were excluded from the analysis. Responses from the 
remaining 215 respondents were included in the analysis. 
 
Procedures  
General guidelines for cross-cultural adaption of measures was followed to translate 
the FSFI, with the use of multi-step procedures of translation, back translation, expert 
reviewing, and pilot testing (Sousa and Rojjanasrirat, 2011). First, the English version of the 
original FSFI was translated into Chinese by two translators independently. Discrepancies 
were solved by discussion. Second, the Chinese version of the scale was back-translated into 
English by two other bilingual researchers who were native Chinese speakers fluent in 
English. Third, a committee of eight bilingual nurses with expertise in research and clinical 
practice reviewed the original, translated, and back-translated versions to ensure each 
translated item reflected to the original one. Agreement on the final translation was achieved 
among committee members. Lastly, the translated scale was pilot tested twice with 10 
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cervical cancer patients with different educational levels to check their understanding of the 
scale items and response options. Some amendments were made based on the feedback 
received. The modified scale was tested again with the same group of patients, and no 
misunderstanding was found.  
 
Instruments 
Two instruments were used for data collection: the FSFI (Chinese version) and a 
general questionnaire. The general questionnaire was used to collect personal 
social-demographic data such as age, education, and occupation, as well as clinical data such 
as stage of cancer and type of therapy.  
Originally developed in the English language, the FSFI is a self-reporting 
multidimensional instrument for assessing FSD (Rosen et al., 2000). The scale was initially 
validated among a group of women with sexual arousal disorder and a control group of 
women without this disorder. There are 19 items arranged in six subscales or domains: 
including two items on desire (questions 1-2), four items on arousal (questions 3-6), four 
items on lubrication (questions 7-10), three items on orgasm (questions 11-13), three items on 
satisfaction (questions 14-16), and two items on pain (questions 17-19). The score ranges of 
individual items are 1-5 for four items (1, 2, 15, and 16) and 0-5 for the rest of the 15 items, 
with zero indicating no sexual intercourse over the past four weeks. There are six separate 
scores, one for each domain, as well as an overall score of the total scale. Each subscale has a 
maximum score of 6 which can be obtained by adding the scores of individual domain items 
and multiplying the sum by a respective domain factor, which is 0.6 for desire, 0.3 for arousal 
and lubrication, and 0.4 for orgasm satisfaction and pain. The total score of the full scale is 
the sum of the six subscale scores and can range from 2 to 36, with a higher score indicating a 
higher level of sexual functioning. 
In terms of reliability and validity of the FSFI, in its original development, Rosen et al. 
(2000) found the scale had high levels of internal reliability (Cronbach α = 0.97), good 
test-retest reliability over 2-4 weeks (r = 0.84), and adequate construct validity as confirmed 
by discriminant and divergent validity. The psychometric properties of the scale are also 
supported by studies carried out with cancer patients. For example, Baser et al. (2012) 
validated the scale with 181 women suffering from various cancers, confirming its validation 
via a factor analysis and reliability as indicated by Cronbach’s alpha of 0.94 and item-total 
correlations between 0.44 and 0.79. Similarly, in a validation study of 399 breast cancer 
survivors, Bartula and Sherman (2015) provided evidence of psychometric properties of the 
scale as shown by a factor analysis, convergent and divergent validity, internal consistency (α 
= 0.83-0.96), and test-retest reliability (r = 0.74-0.86). Studying women with mixed sexual 
dysfunctions, Wiegel et al. (2005) suggested a total score less than 26.55 as a specific clinical 
cut-off score for potential classification of women’s sexual dysfunction. 
 
Statistical analysis 
SPSS version 18 statistical software and AMOS software version 18 were used to 
perform the data analysis. Descriptive statistics including means, median, frequencies, and 
percentage were calculated to show the distribution of personal social-demographic 
information, clinical characteristics, and sexual function. Skewness, kurtosis, histograms, and 
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Q-Q were performed to examine normality distribution of the data. Data were considered to 
be normally distributed if the skewness or kurtosis statistics were no more than 1.96 times 
their respective standard error (Field, 2013). 
Internal consistency reliability of the scale was tested by Cronbach’s alpha. An alpha 
value above 0.7 indicates acceptable internal consistency (Streiner and Norman, 2008). 
Test-retest reliability was tested by Pearson correlations, and a correlation coefficient above 
0.7 is considered generally good (Streiner and Norman, 2008). 
Construct validity was evaluated by principal component analysis and confirmatory 
factor analysis. The principal component analysis was conducted using oblique rotation after 
suitability of the data for the analyses being confirmed by Kaiser-Meyer Olkin Measure of 
0.5-1.0 (Kaiser, 1974) and Bartlett's Test of Sphericity with statistical significance (p < 0.05) 
(Bartlett, 1954). Multiple goodness-of-fit measurement indices was used to determine a 
model fit for confirmatory factor analysis, with the following criteria applied: CMIN/DF ratio 
(< 3), Goodness-of-Fit Index (GFI ≥ 0.90), Comparative Fit Index (CFI ≥ 0.90), and the Root 
Mean Square Error of Approximation (RMSEA < 0.08) (Hu and Bentler, 1999). RMSEA 
values of 0.80-0.10 indicate a reasonable fit (Sugawara and MacCallum, 1993).  
To explore variability of the scale, floor and ceiling effects were analysed. A cut off 
score of > 15% on the minimum or maximum scores for each item indicates the presence of 
floor and/or ceiling effects (Terwee et al., 2007). 
All statistical tests performed were two-tailed and a p-value < 0.05 was considered 
statistically significant.  
 
Ethical considerations 
The research was approved by an independent ethics committee which was identified 
by the Hunan Cancer Hospital, China (Approval number: 2013year34th). General ethical 
principles in health and social care were followed. An information sheet with details about 
the study and the nature of participation was provided. Participation was voluntary and all 
respondents provided a signed consent form. Respondents were assured that their care was 
not affected by whether or not they participated in the study and that any information they 
provided remained unidentifiable and confidential. Each participant received a towel as 
incentive for her participation.  
 
RESULTS 
Table 1 shows self-reported demographic profiles of the 215 patients who responded. 
The mean age was 43.25 years ± 7.05 (range 19-63 years). The largest proportion of 
respondents for each characteristic were housewives (58.6%); in the age group of 40-49 years 
(53.5%); educated at secondary level (67.0%); lived in the countryside (62.8%). The majority 
of respondents were in either Stage I (51.2%) or Stage II (36.2%) of cancer. All respondents 
had surgery and almost two thirds had also received radiotherapy. 
Overall data distribution showed a positive skewness of 0.14. The skewness or kurtosis 
statistics were no more than 1.96 times their respective standard error (0.14/0.17=0.82, 
0.19/0.33=0.58, respectively), indicating the data were normally distributed. The data 
normality was also confirmed by histograms and Q-Q plots. The mean score of the total FSFI 
scale was 20.65±4.77 (range 8.40-33.70). Of all respondents, 86.5 % (186/215) had a score 
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below the cut-off point of sexual dysfunction (26.55).  
In terms of internal consistency reliability (Table 2), the Cronbach α coefficients were 
0.94 for the full score and 0.72-0.90 for the domains; item-total correlation coefficients 
ranged between 0.47 and 0.83 (p < 0.05); domain-total correlation coefficients were 
0.59-0.89 (p < 0.05). For test-retest reliability, the Pearson correlation coefficient between 
two assessments in an interval of 2-4 weeks was 0.84 (p < 0.001) for the total scale, and 
ranged between 0.68 (Arousal) and 0.83 (Lubrication) for the six subscales with all 
correlations statistically significant (p < 0.001).  
For principal component analysis, the Kaiser-Meyer Olkin Measure of the FSFI scores 
was satisfactory (0.91) and the Bartlett's Test of Sphericity was statistically significant 
(χ2=3184.896, p < 0.001), indicating the data were suitable for the analysis to explore the 
dimensions of the scale. Principal component analysis using oblique rotation (Table 3) 
identified five factors accounting for 77.57% of the total variance in responses. Each factor 
had an eigenvalue greater than 1. The first factor consisted of a mixture of desire/arousal, and 
the rest were lubrication, orgasm, satisfaction, and pain. Each item loaded mainly on the 
single factor associated with its relevant domain with three exceptions. Item 11 “Orgasm: 
frequency” and item 12 “Orgasm: difficulty” in the Orgasm subscale cross loaded on the 
Desire/Arousal and Lubrication factors at similar factor loadings. Item 14 “Satisfaction: with 
amount of closeness with partner” in the Satisfaction subscale loaded on the Orgasm subscale 
factor. 
For confirmatory factor analysis, a six-factor model was computed first, which 
indicated the model was not a good fit to the data (CMIN/DF=3.12, GFI=0.83, CFI=0.91, 
RMSEA=0.100). Then a five-factor model was computed (Figure 1). The findings 
(CMIN/DF=3.08, CFI=0.91, GFI=0.83, RMSEA=0.099) indicated that the five-factor model 
was a reasonable fit to the data. The five factors included desire/arousal, lubrication, orgasm, 
satisfaction, and pain. 
With regard to floor and ceiling effects, for each item across all 19 items scoring on 
either the highest or the lowest score did not exceed the 15% cut off, indicating the absence 
of either ceiling or floor effects (Table 3). 
 
DISCUSSION 
The purpose of this study was to examine the psychometric properties and performance 
of a Chinese version of the 19-item FSFI in cervical cancer survivors in mainland China. The 
results indicated that the scale had satisfactory reliability and validity for use in a sample of 
women with cervical cancer.  
The mean score of the total FSFI was 20.65±4.77, and 86.5% of the sample had a total 
score below 26.55, a cut-off point of FSFI-based estimation of FSD as suggested by Wiegel 
et al. (2005). These findings indicate that the sexual functioning of women in our study was a 
serious issue of concern. The mean score seemed low, compared to the mean score of 
24.75±6.75 on FSFI as reported in a study of women with various cancers (Baser et al., 2012). 
This may be due to the variations in two samples. Our study only included patients with 
cervical cancer in China where women tend to hold traditional Chinese values towards sexual 
behaviour, while Baser et al. (2012) studied women with different types of gynaecologic 
cancers in the USA.  
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Our findings revealed good internal consistency reliability for the FSFI, as demonstrated 
by Cronbach α coefficients (0.94 for the total scale; 0.72-0.90 for the domains) and item-total 
correlation coefficients (0.47-0.83). High test-retest reliability over 2-4 weeks (r = 0.84) was 
also reported. These findings are consistent with previous studies conducted by others (i.e. 
Rosen et al., 2000; Baser et al., 2012; Bartula and Sherman, 2015). For example, in the 
scale’s original development among women with or without sexual dysfunction, Rosen et al. 
(2000) obtained Cronbach’s α values of 0.82-0.97 and test-retest reliability coefficients of 
0.79-0.86. Similarly, Baser et al. (2012) reported Cronbach α coefficient of 0.94 and 
item-total correlation coefficients of 0.44-0.79 among survivors with various cancers, while 
Bartula and Sherman (2015) found Cronbach α coefficients of 0.83-0.96 and test-retest 
reliability of 0.74-0.86 among breast cancer survivors. These findings have repeatedly shown 
satisfactory reliability of the FSFI, suggesting that the scale can be used to measure levels of 
sexual functioning in diverse populations including female cancer survivors. 
Five factors emerged from our principal component analysis via oblique rotation, 
including desire/arousal, lubrication, orgasm, satisfaction, and pain. This five-factor structure 
was also confirmed in our confirmatory factor analysis, in which the five-factor model was 
shown to be a reasonable fit to our data. The overlap among the domains of desire and 
arousal may reflect to our respondents’ perception of sexual intercourse, where the distinction 
between sexual desire and arousal was not clear. A similar five-factor solution was also 
reported by Baser et al. (2005) in a study of women with various cancers. In fact, in the 
FSFI’s original validation study, the same five-factor solution was identified initially, but the 
desire/arousal domain was separated later into two factors based on a clinical decision (Rosen 
et al., 2000). The pattern of five-factor loadings in our study corresponded closely with that 
reported in previous studies of women with sexual dysfunction (Wiegel et al., 2005; Baser et 
al., 2012). Furthermore, Opperman et al. (2013) evaluated four different models of the FSFI 
using confirmatory analysis and found that a five-factor model demonstrated adequate fit, 
although a six-factor model had significantly better fit than the five-factor model. Statistical 
support for a five-factor model, as demonstrated in our study and previous studies, suggests 
the interconnected nature of women’s sexual desire and arousal and supports the argument on 
combining these two domains into one disorder (Brotto, 2010; Graham, 2010). 
Compared to the original FSFI six-factor structure, there are some discrepancies 
between our study and the study conducted by Rosen et al. (2000) in terms of factor loadings 
of individual items. In our study, items 11 and 12 in the Orgasm subscale cross loaded on the 
Desire/Arousal and Lubrication factors at similar factor loadings. This may be explained by 
our respondents’ interpretation of orgasm. A patient might decide whether she had orgasm 
based on the frequency of her desire/arousal and the extent of lubrication. If she frequently 
had desire, arousal, and lubrication, she might have interpreted it as the result of orgasm. Item 
14 in the Satisfaction subscale loaded on the Orgasm subscale. The explanation may lie in 
that a respondent might consider orgasm was closely related to her satisfaction with her 
partner during sexual intercourse. Therefore, a respondent might have reported orgasm 
because she was satisfied with her partner. These findings may highlight the important role 
that emotional intimacy with a partner can pay in the sexual functioning of women with 
cancer (Baser et al., 2012).   
In relation to variability, although the mean score was low our data distribution did not 
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show evidence of a floor effect, with a less than 15% scoring on the minimum score for each 
item. This finding indicates the ability of FSFI to capture variation in our data and is 
consistent with the study by Wylomanski et al. (2014) who did not find a floor effect in a 
study of French women seeking gynaecology consultation, although two items (items 9 and 
10) had a ceiling effect. It appears that data variability was evident in our study; however, the 
issue of possible ceiling effects of the FSFI is worth further investigation.   
 
Limitations 
This study aimed to analyse the psychometric properties and performance of the 
translated 19-item Chinese version of the FSFI. Despite promising results, there are some 
limitations of our study. First, the respondents were recruited from one oncology hospital, and 
therefore findings from the current study may not be able to be generalised to patients with 
cervical cancer from other areas of China and beyond. Second, the sample size of our study 
was small, limiting the generalisability of our findings. Despite these limitations, some 
clinical implications can be drawn from our findings. 
 
Clinical implications 
This study is the first systematic assessment of a Chinese version of the FSFI in terms 
of its reliability, construct validity, and variability among a sample of cervical cancer 
survivors in China. Our findings have shown some evidence of good psychometric properties 
of this scale, suggesting that the scale could be recommended for use in clinical settings to 
measure sexual functioning in cervical cancer patients, so that those who may suffer from 
sexual dysfunction could be identified for early intervention. The absence of a floor effect as 
we found in our data suggests that the scale is suitable for use in women with a low level of 
sexual functioning. 
However, attention must be paid when the FSFI is administered to women with little or 
no sexual activity in the past four weeks. Of the 19 items, 15 items have response options of 
“no sexual activity” or “did not attempt intercourse”, which are assigned a score of zero. A 
domain score of zero can only indicate that no sexual activity is reported, but it conveys no 
useful information about this specific domain. In the original validation study of the FSFI, 
Rosen et al. (2000) indicated that it would be appropriate to use the scale only for women 
with some level of recent sexual activity, although a reanalysis of the factor structure showed 
little change following exclusion of data from women with no recent sexual activity. Rosen et 
al. (2000) argue that when a score of zero was assigned for an item, it is not clear whether 
this was due to a respondent’s dysfunctions in the symptoms assessed by the item, or due to 
other reasons such as lack of a sexual partner or a poor marital relationship. Baser et al. (2012) 
strongly recommend that when researchers use the FSFI among women with cancer, specific 
attention needs to be paid not only to respondents’ sexual activity levels but also to their 
reasons for sexual inactivity. 
 
CONCLUSION 
In conclusion, the Chinese version of the FSFI we tested has satisfactory psychometric 
properties and performance when used in a sample of women with cervical cancer in China. 
Similar to the original English version, this Chinese version of the scale has good reliability 
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and validity as demonstrated by internal consistency, test-retest reliability, construct validity, 
and variability. This scale has proven to be a reliable and valid instrument for measuring 
sexual functioning in Chinese women with cancer for research and clinical purposes. 
However, caution should be paid when the scale is used in women with little recent sexual 
activity. It would be valuable for future research to confirm its psychometric properties and 
performance among a large sample of cervical cancer patients across China. 
Accepted manuscript 
Liu, Yu, Chen et al. (2016) 
 
Page 10 of 17 
 
REFERENCES 
American Psychiatric Association & American Psychiatric Association. Task Force on 
DSM-IV 2000. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, 
fourth text revision, ed. American Psychiatric Association, Washington, DC. 
Bartlett, M.S., 1954. A note on multiplying factors for various approximations. Journal of the 
Royal Statistical Society 16, 296-298. 
Bartula, I., Sherman, K.A., 2015. The Female Sexual Functioning Index (FSFI): evaluation of 
acceptability, reliability, and validity in women with breast cancer. Supportive Care in 
Cancer DOI 10.1007/s00520-015-2623-y. 
Baser, B.E., Li, Y.L., Carter, J., 2012. Psychometric Validation of the Female Sexual 
Function Index (FSFI) in Cancer Survivors. Cancer 118, 4606-4618. 
Basson, R., Berman, J., Burnett, A., Derogatis, L., Ferguson, D., Fourcroy, J. et al., 2001. 
Report of the International Consensus Development Conference on Female Sexual 
Dysfunction: Definitions and Classifications. Journal of Sex & Marital Therapy 27, 
83-94. 
Bergmark, K., Avall-Lundqvist, E., Dickman, P.W., Henningsohn, L., Steineck, G., 2002. 
Patient-rating of distressful symptoms after treatment for early cervical cancer. Acta 
Obstet Gynecol Scandia 81, 443-450. 
Berner, M.M., Kriston, L., Zahradnik, H.P., H a rter, M., Rohde, A., 2004. Validity and 
Reliability of the German Female Sexual Function Index (FSFI-d). Geburtsh 
Frauenheilk 64, 293-303. 
Brotto, L.A., 2010. The DSM diagnostic criteria for hypoactive sexual desire disorder in 
women. Archives of Sexual Behavior 39, 221-239. 
Cervical Cancer-Free Coalition, 2014. Cervical cancer global crisis card. Available at: 
http://www.cervicalcancerfreecoalition.org/wp-content/uploads/Cervical-Cancer-Global-
Crisis-Card_2013.pdf (accessed 20.08.14).  
Chen, W., Zheng, R., Zhang, S., Zhao, P., Li, G., Wu, L., He, J., 2013. Report of incidence 
and mortality in China cancer registries, 2009. Chinese Journal of Cancer Research 
25(1), 10-21.  
DeRogatis, L.R. 2008. Assessment of sexual function/dysfunction via patient reported 
outcomes. International Journal of Impotence Research 20, 35-44. 
Donovan, K.A., Taliaferro, L.A., Alvarez, E.M., Jacobsen, P.B., Roetzheim, R.G., Wenham, 
R.M., 2007. Sexual health in women treated for cervical cancer: characteristics and 
correlates. Gynecologic Oncology 104, 428-434. 
Field, A., 2013. Discovering Statistics using IBM SPSS Statistics, Fourth ed. Sage, London.  
Graham, C.A., 2010. The DSM diagnostic criteria for female sexual arousal disorder. 
Archives of Sexual Behavior 39, 240-255. 
Hu, L., Hu, P.C., 2008. Development of Sexual Quality of Life Questionnaire for Women. 
Chinese Mental Health Journal 22, 447-450. 
Hu, L., Bentler, P.M., 1999. Cut off criteria for fit indexes in covariance structure analysis: 
Conventional criteria versus new alternatives. Structural Equation Modeling 6, 1-55. 
Jeffery, D.D., Tzeng J. P., Keefe, F. J., Porter, L. S., Hahn, E.A., Flynn, K. E., et al., 2009. 
Initial report of the cancer Patient-Reported Outcomes Measurement Information 
System (PROMIS) sexual function committee. Cancer 115, 1142-1153. 
Accepted manuscript 
Liu, Yu, Chen et al. (2016) 
 
Page 11 of 17 
 
Kaiser, H.F., 1974. An index of factorial simplicity. Psychometrika 39, 31-36. 
Lammerink, E.A.G., de Bock, G.H., Pras, E., Reyners, A.K.L., Mourits, M.J.E., 2012. Sexual 
functioning of cervical cancer survivors: A review with a female perspective. Maturitas 
72, 296-304. 
Levin, A.O., Carpenter, K.M., Fowler, J.M., Brothers, B.M., Andersen, B.L., Maxwell, G.L., 
2010. Sexual morbidity associated with poorer psychological adjustment among 
gynecological cancer survivors. International Journal of Gynecological Cancer 20, 
461-470. 
NHS, 2014. Cervical cancer – treatment. Available at: 
http://www.nhs.uk/Conditions/Cancer-of-the-cervix/Pages/Treatment.aspx (accessed 
22.07.14).  
Opperman, E.A., Benson, L.E., Milhausen, R.R., 2013. Confirmatory factor analysis of the 
Female Sexual Function Index. Journal of Sex Research 50(1), 29-36. 
Pechorro, P.S., Vieira, R.X., Calvinho, A.M., Poianes, C., Diniz, J.M.A., 2012. 
Cross-validation of the Portuguese Version of the Female Sexual Function Index (FSFI). 
Androl 10, 113-120. 
Rellini, A.H., Nappi, R.E., Vaccaro, P., Ferdeghini, F., Abbiati, I., Meston, C.M., 2005. 
Validation of the McCoy Female Sexuality Questionnaire in an Italian sample. Archives 
of Sexual Behavior 34, 641-647. 
Reis, N., Beji, N.K., Coskun, A., 2010. Quality of life and sexual functioning in 
gynecological cancer patients: Results from quantitative and qualitative data. European 
Journal of Oncology Nursing 14, 137-146. 
Rosen, R., Brown, C., Heiman, J., Leiblum, S., Meston, C., Shabsigh, R., Ferguson, D., 
D’Agostino, R.J., 2000. The Female Sexual Function Index (FSFI): a multidimensional 
self-report instrument for the assessment of female sexual function. Journal of Sex and 
Marital Therapy 26, 191-208. 
Rosen, R.C. 2002. Assessment of female sexual dysfunction: review of validated methods. 
Fertility and Sterility 77 (Supplement 4), s89-s93. 
Sousa, V.D., Rojjanasrirat, W., 2011. Translation, adaptation and validation of instruments or 
scales for use in cross-cultural health care research: a clear and user-friendly guideline. 
Journal of Evaluation in Clinical Pracitce 17, 268-274. 
Streiner, D.L., Norman, G.R., 2008. Health Measurement Scales. A Practical Guide to Their 
Development and Use, Fourth ed. Oxford University Press, Oxford. 
Sugawara, H.M., MacCallum, R.C., 1993. Effect of estimation method on incremental fit 
indexes for covariance structure models. Applied Psychological Measurement 17, 
365-377. 
Terwee, C.B., Bot, S.D.M., de Boer, M.R., van der Windt, D.A.W.M., Knol, D.L.,Dekker, J., 
et al., 2007. Quality criteria were proposed for measurement properties of health status 
questionnaires. Journal of Clinical Epidemiology 60, 34-42.  
WHO (2013) Human papillomavirus (HPV) and cervical cancer. Available at: 
http://www.who.int/mediacentre/factsheets/fs380/en/ (accessed 08.07.2014). 
Wiegel, M., Meston, C., Rosen, R., 2005. The female sexual function index (FSFI): cross- 
validation and development of clinical cutoff scores. Journal of Sex and Marital Therapy 
31, 1-20. 
Accepted manuscript 
Liu, Yu, Chen et al. (2016) 
 
Page 12 of 17 
 
Wilmoth, M.C., Spinelli, A., 2000. Sexual implications of gynecologic cancer treatments. 
Journal of Obstetric, Gynecologic, and Neonatal Nursing 29(4), 413-421. 
Wylomanski ,S., Bouquin, R., Philippe, H.J., Poulin, Y., Hanf, M., Dre´no, B., Rouzier, R., 
Que´reux, G., 2014. Psychometric properties of the French Female Sexual Function 
Index (FSFI). Quality of Life Research 23, 2079-2087. 
Accepted manuscript 
Liu, Yu, Chen et al. (2016) 
 
Page 13 of 17 
 
Table 1 Sample characteristics (n=215) 
 n % 
Age    
Aged 29 or under 23 10.70 
Aged 30-39 61 28.37 
Aged 40-49 115 53.49 
Aged 50 or above 16 7.44 
Education level   
Junior secondary or below 46 21.40 
Secondary 144 66.97 
College or above 25 11.63 
Occupation    
Professional worker 89 41.40 
Housewife  126 58.60  
Place of residence    
Urban  80 37.21 
Countryside  135 62.79 
Stage of cancer   
Stage I 110 51.16 
Stage II 78 36.28 
Stage III 27 12.56 
Treatment    
Hysterectomy only 22 10.23 
Hysterectomy and radiotherapy  51 23.72 
Hysterectomy and chemotherapy  52 24.19 
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Table 2 Performance of the Female Sexual Function Index (n=215) 
Domain Item Mean ±SD Cronbach α 
if item 





g effect % 
Desire 1.Desire:frequency 2.70±0.93 .94 .56 7.44/4.18 
 2. Desire: level  2.60±0.81 .94 .73 8.37/2.33 
Doman: Desire 3.18±0.92 .72 .75 4.19/2.33 
Arousal 3. Arousal: frequency  2.65±0.97 .94 .72 11.16/3.72 
4. Arousal: level  2.84±0.92 .94 .76 7.44/3.72 
5. Arousal: 
confidence  
2.97±0.94 .94 .79 6.51/4.65 
6. Arousal: 
satisfaction  
2.64±0.89 .94 .72 7.44/2.33 
Domain: Arousal 3.33±0.97 .89 .86 2.33/0.47 
Lubrication 7. Lubrication: 
frequency 
2.77±0.93 .94 .83 6.05/4.65 
8. Lubrication: 
difficulty 








2.98±1.01 .94 .71 5.58/11.63 
Domain: Lubrication 3.49±1.03 .90 .84 1.40/1.40 
Orgasm 11. Orgasm: 
frequency 
2.60±0.92 .94 .80 9.76/3.26 
12. Orgasm: 
difficulty 
2.86±1.05 .94 .77 8.37/10.70 
13. Orgasm: 
satisfaction 
3.15±0.95 .94 .74 5.58/7.44 
Domain: Orgasm 3.45±1.01 .83 .89 3.72/0.93 
Satisfaction 14. Satisfaction: with 
amount of closeness 
with partner 
3.18±1.05 .94 .75 5.12/11.63 
15. Satisfaction with 
sexual relationship 
2.65±0.91 .94 .69 10.23/0.47 
16. Satisfaction: with 
overall sex life 
2.74±1.03 .94 .67 10.70/2.79 
Domain: Satisfaction 3.43±1.05 .85 .81 2.79/0.47 
Pain 17. Pain: frequency 
during vaginal 
penetration 
3.09±0.97 .94 .57 4.19/8.84 
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18. Pain: frequency 
following vaginal 
penetration 
3.24±1.03 .94 .55 6.51/11.63 
19. Pain: level during 
or following vaginal 
penetration 
3.11±1.00 .94 .47 5.58/12.09 
Domain: Pain 3.78±1.08 .89 .59 4.19/8.84 
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Table 3 Principal components analysis using oblique rotation (n=215) 
Item Factors 
 1 2 3 4 5 
1.Desire:frequency .76* .22 -.32 .38 .06 
2. Desire: level .86* .22 -.47 .44 -.37 
3. Arousal: frequency .86* .20 -.48 .43 -.37 
4. Arousal: level .85* .22 -.53 .46 -.45 
5. Arousal: confidence .83* .25 -.58 .50 -.48 
6. Arousal: satisfaction .73* .38 -.51 .49 -.27 
7. Lubrication: frequency .67 .44 -.82* .49 -.37 
8. Lubrication: difficulty .43 .33 -.92* .45 -.28 
9. Lubrication: frequency of maintaining .66 .33 -.79* .54 -.30 
10. Lubrication: difficulty in maintaining .41 .33 -.92* .43 -.32 
11. Orgasm: frequency .68* .36 -.69* .49 -.58* 
12. Orgasm: difficulty .57 .35 -.75* .45 -.58* 
13. Orgasm: satisfaction .56 .36 -.54 .53 -.76* 
14. Satisfaction: with amount of closeness with 
partner 
.48 .49 -.51 .65* -.71* 
15. Satisfaction with sexual relationship .45 .31 -.49 .95* -.30 
16. Satisfaction: with overall sex life .47 .29 -.44 .95* -.24 
17. Pain: frequency during vaginal penetration .27 .90* -.34 .41 -.14 
18. Pain: frequency following vaginal penetration .23 .93* -.33 .25 -.25 
19. Pain: level during or following vaginal 
penetration 
.16 .90* -.28 .22 -.12 
Eigenvalue 7.16 4.15 6.75 5.35 3.19 
% Total variance accounted for by each factor 50.34 11.17 6.48 5.92 3.66 
% Total variance accounted for by 5-factor solution 77.57 
*Items with the highest loadings within each factor 
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Figure 1. Confirmatory factor analysis: five-factor model of the Female Sexual Function 
Index 
e: item; D: desire; A: arousal; L: lubrication; O: orgasm; S: satisfaction; P: pain 
 
 
